Bayer mediator says glyphosate settlement talks slowed by coronavirus


FILE PHOTO: Logo of Bayer AG is pictured at the annual results news conference of the German drugmaker in Leverkusen, Germany February 27, 2019. REUTERS/Wolfgang Rattay/File Photo

(Reuters) – Negotiations between Bayer AG and plaintiff lawyers to settle claims its glyphosate-based weedkillers cause cancer have been slowed by the coronavirus outbreak, according to the mediator in the talks.

“Everything has been set back by the virus, all the discussions, any finalizing of the settlement,” court-appointed mediator Ken Feinberg told Reuters.

“I remain cautiously optimistic that there’ll be a settlement, although not this month,” he added.

Bayer said mediation discussions continued in good faith and that it could not comment further.

German weekly Wirtschaftswoche first reported the delay.

Reporting by Tina Bellon in New York; Writing by Ludwig Burger in Frankfurt; Editing by Thomas Seythal

Products You May Like

Articles You May Like

Episode 212: Coping with coronavirus, Earth Day goes digital, how ESG funds are faring
Could the Ohio River have rights? A movement emerges, testing the power of local control
Vaping additive blamed for outbreak produces ‘exceptionally toxic’ byproducts
Daily briefing: Three things all governments and their science advisers must do now to fight COVID-19
Caring for Dogs (and Cats) in Times of Coronavirus

Leave a Reply

Your email address will not be published. Required fields are marked *